GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $207,000 | -1.0% | 4,759 | +0.5% | 0.02% | 0.0% |
| Q4 2021 | $209,000 | -14.3% | 4,736 | -26.9% | 0.02% | -62.1% |
| Q3 2020 | $244,000 | -6.2% | 6,482 | +1.9% | 0.06% | -14.7% |
| Q2 2020 | $260,000 | +7.0% | 6,363 | -1.1% | 0.07% | -18.1% |
| Q1 2020 | $243,000 | -23.1% | 6,434 | -4.4% | 0.08% | 0.0% |
| Q4 2019 | $316,000 | +11.3% | 6,732 | +1.1% | 0.08% | +1.2% |
| Q3 2019 | $284,000 | +14.5% | 6,660 | +7.3% | 0.08% | +2.5% |
| Q2 2019 | $248,000 | +8.8% | 6,205 | +13.3% | 0.08% | +8.1% |
| Q1 2019 | $228,000 | +132.7% | 5,475 | +113.2% | 0.07% | +76.2% |
| Q4 2018 | $98,000 | -6.7% | 2,568 | -4.1% | 0.04% | -12.5% |
| Q1 2018 | $105,000 | +218.2% | 2,677 | +185.1% | 0.05% | +220.0% |
| Q4 2017 | $33,000 | – | 939 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |